10.3390/nu11071541 186
Compared to bariatric outcomes, for GLP-1 agonists the effect of weight loss are less, but still significant: Semaglutide 2.4 mg: 1218% mean weight loss at 1 year in adherent cohorts, often around 1317% in practice Tirzepatide 1015 mg: 1620% weight loss at 72 weeks
Contacts Raymond MacDougall NIH/NHGRI 301-402-0911 [email protected] Anne Oplinger NIH/NIAID 301-402-1663 [email protected] Eric Jome Illinois State University 309-438-5631 [email protected] Last updated: May 15, 2012
Additionally, although a continuous value of serum GPX-3 concentration did not show significant predictive potential for poor outcomes, we wondered whether a categorical value of serum GPX-3 concentration according to its cut-offs of poor outcomes such as all-cause mortality, ESKD, CVA, and ACS could be a significant predictor of those poor outcomes
Biochemical studies on the cardioprotective effect of glutamine on tissue antioxidant defense system in isoprenaline-induced myocardial infarction in rats
Environmental toxins, poor diet, and lack of sleep can further deplete these vital stores
